Abiopharma

General Announcement: ISSUANCE OF SHARES PURSUANT TO EXERCISE OF WARRANTS

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Director Xia Yu 🟢 acquired 533.6K shares of Summit Therapeutics Inc. (SMMT) at $18.74 ($10.0M) Transaction Date: Oct 21, 2025 | Filing ID: 000004

Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma

QuidelOrtho Corporation - Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

ResMed Inc. Daily Stock Update

Healthy Extracts’ Gummy USA Secures 6 Million Gummy Follow-On Order from Woman’s Health Nutraceutical Leader

Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025

Blackstone i TPG przejmą Hologic za kwotę 79 USD za akcję

Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights

UTHR: Notification

Cingulate’s Lead ADHD Candidate CTx-1301 Selected for Podium Presentation at AACAP Annual Meeting

CoyaTherapeutics - Coya Therapeutics Announces Proposed Public Offering of Common Stock